tiprankstipranks
Clinuvel Pharmaceuticals Limited (CLVLF)
OTHER OTC:CLVLF
US Market
CLVLF
Clinuvel Pharmaceuticals
RESEARCH TOOLSreports
Want to see CLVLF full AI Analyst Report?

Clinuvel Pharmaceuticals (CLVLF) Income Statement

43 Followers

Clinuvel Pharmaceuticals Income Statement

Last quarter (Q2 2026), Clinuvel Pharmaceuticals 's total revenue was AU$36.93M, an increase of 14.49% from the same quarter last year. In Q2, Clinuvel Pharmaceuticals 's net income was AU$10.44M. See Clinuvel Pharmaceuticals ’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
AU$ 95.02MAU$ 88.18MAU$ 78.32MAU$ 65.72MAU$ 47.98M
Gross Profit
AU$ 79.14MAU$ 80.45MAU$ 50.59MAU$ 46.62MAU$ 35.20M
Operating Expenses
AU$ 33.40MAU$ 31.30MAU$ 9.68MAU$ 13.53MAU$ 8.51M
Depreciation and Amortization
AU$ 1.18MAU$ 1.14MAU$ 789.41KAU$ 757.83KAU$ 861.43K
EBITDA
AU$ 57.20MAU$ 56.28MAU$ 46.37MAU$ 35.08MAU$ 28.19M
Operating Income
AU$ 45.73MAU$ 48.01MAU$ 40.91MAU$ 33.08MAU$ 26.70M
Other Income/Expenses
AU$ 5.82MAU$ 2.67MAU$ 1.48MAU$ -1.77MAU$ -983.49K
Pretax Income
AU$ 51.55MAU$ 50.68MAU$ 45.58MAU$ 34.32MAU$ 25.71M
Net Income
AU$ 36.17MAU$ 35.64MAU$ 30.60MAU$ 20.88MAU$ 24.73M
Per Share Metrics
Basic EPS
AU$ 0.72AU$ 0.72AU$ 0.62AU$ 0.42AU$ 0.50
Diluted EPS
AU$ 0.72AU$ 0.70AU$ 0.59AU$ 0.40AU$ 0.48
Weighted Average Shares Outstanding
 50.08M 51.05M 49.41M 49.41M 49.41M
Weighted Average Shares Outstanding (Diluted)
 50.38M 51.03M 51.82M 51.78M 51.13M
Currency in AUD

Clinuvel Pharmaceuticals Earnings and Revenue History